ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 168 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,510,490 | +12.2% | 1,001,000 | +8.8% | 1.52% | +7.3% |
Q2 2023 | $18,280,400 | +16.0% | 920,000 | 0.0% | 1.41% | +35.9% |
Q1 2023 | $15,759,600 | -5.3% | 920,000 | +8.2% | 1.04% | +0.1% |
Q4 2022 | $16,634,500 | +64.7% | 850,000 | +34.3% | 1.04% | +115.6% |
Q3 2022 | $10,100,000 | +16.0% | 632,822 | 0.0% | 0.48% | +12.4% |
Q2 2022 | $8,708,000 | -10.4% | 632,822 | +3.3% | 0.43% | -16.4% |
Q1 2022 | $9,719,000 | -27.4% | 612,822 | 0.0% | 0.51% | -19.0% |
Q4 2021 | $13,378,000 | -16.2% | 612,822 | +14.7% | 0.63% | -23.4% |
Q3 2021 | $15,964,000 | – | 534,085 | – | 0.83% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |